skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: TFSA top up for 2023. I hold all IWO in the account currently. My crystal ball doesn't like the current USD:CAD outlook so buying USD with CAD to get IWO at the moment doesn't feel like a good move. Does anything in the balance or growth portfolio look particularly attractive as a buy? I hold OTEX and ENGH as tech stocks, both have been adequately beaten up to be buys but I hate owning the same stock in multiple accounts so would consider a different CAD stock for the TFSA account if you can think of one. So long way to ask: just suck it up and buy, IWO, buy ENGH, buy OTEX or buy ??? as it is your top pick right now. 5 year hold.
Read Answer Asked by Tom on January 05, 2023
Q: I had asked a question about a year ago about companies of interest for EV investing and I had not mentioned WBX but your answer came back as ranking it #2 out for 4 companies. Since then it has tanked more than 80%. Could you update your opinion on this company and share your insights of why it has faired worse than the others despite your ranking,
Read Answer Asked by Denis on January 04, 2023
Q: Hello Peter,

Wishing you and the 5i family a happy Christmas and the very best for the new year.

I wonder if you have an opinion on the Calgary based small cap Exro Technologies. If the 5i research team has looked at this one, would it be possible to have your preference between common shares and the warrant EXRO.WT. The company has closed another round of debentures that would probably be traded on the exchange.
Thank you in advance.
Regards
Rajiv
Read Answer Asked by Rajiv on January 04, 2023
Q: hi folks:

below is your reply/update from july 12,2022 on these 4 pot stocks

seems like the only catalyst will be the pending legislative change in the usa

i am curious for your update on these names, with a comment on potential survivability (or, i guess, lack of same)


thanks again

merry christmas to you and your families


unless that offends you, then happy holidays...............


july2022
GRWG is the smallest of the names, with a market cap of $256.3M, whereas GTII has a market cap of $2.8B, TRUL $3.0B, and CURA $4.6B. Revenue growth is strong among all four companies. GRWG has had the most volatility in price and its balance sheet is quite strong, but it does issue shares to fund its operations. GTII has good profit margins and is at a reasonable valuation (2.0X sales, 30.1X P/E, and 1.3X book value). TRUL has shown volatility in its profitability and its valuation is OK (1.7X sales, 37.3X P/E, and 1.0X book). CURA is not profitable and has a high valuation.

We think that GTII has demonstrated its resiliency and is the strongest of the four names. Although GRWG is the smallest, we like its profitability and strong balance sheet. We would then rank TRUL and CURA following GTII and GRWG. Although, the momentum in shares for all four names is not the greatest and we would prefer to wait until investor appetite for growth stocks has returned before becoming interested in these names.

Read Answer Asked by Robert on January 04, 2023
Q: which of the above companies has a better chance of getting a deal done and what percentage would you give each company of a deal happening.
i know you like converge and its very cheap, i value your opinion. dave
Read Answer Asked by david on January 03, 2023
Q: For a 4 year timeframe, I need to keep two of these stocks. Which two of the four are most likely to grow and be successful?

Thanks
Read Answer Asked by Lucy on January 03, 2023
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!